Vera Therapeutics VERA
NASDAQ VERA
$35.85 +0.86 (+2.47%)
As of: Sep 4, 2026 · 3:58 PM EDT

Vera Therapeutics (VERA) Notes Payables (2021 - 2023)

Analysis

Vera Therapeutics (VERA) Notes Payables (2021 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Vera Therapeutics 2.58 Bn 2.58 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 3.07 Mn
Dec 31, 2022 2.78 Mn
Sep 30, 2022 1.00 Mn
Jun 30, 2022 1.70 Mn
Mar 31, 2022 1.64 Mn
Dec 31, 2021 1.02 Mn
Sep 30, 2021 994,000.00